Hepion PharmaceuticalsHEPA
13F holders, Q1 2024 (March 31)25holders
$2.49avg. 13F price*
At the end of Q1 2024, 25 institutions reported holding Hepion Pharmaceuticals Inc. (HEPA) in their 13F filings. The largest holders were Armistice Capital, LLC ($971K), Vanguard Group Inc. ($392K) and BlackRock Inc. ($207K).
- Company
- Hepion Pharmaceuticals Inc.
- CUSIP
- 426897302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $438 |
| Exits | 1 | $41K |
Ownership 25 holders
| Armistice Capital, LLC | 0.03% | Reduce -6.7% | 390,000 | $971K |
| Vanguard Group Inc. | 0.00% | Reduce -1.9% | 157,360 | $392K |
| BlackRock Inc. | 0.00% | No change | 82,954 | $207K |
| Geode Capital Management, LLC | 0.00% | Add +11.2% | 38,833 | $97K |
| State Street Corp. | 0.00% | No change | 15,676 | $39K |
| Susquehanna International Group, LLP | 0.00% | No change | 14,635 | $36K |
| PNC Financial Services Group, Inc. | 0.00% | Add +173.7% | 7,879 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +17.5% | 1,900 | $5K |
| Morgan Stanley | 0.00% | Reduce -6.1% | 1,357 | $3K |
| Group One Trading LLC | 0.00% | No change | 339 | $844 |
| UBS Group AG | 0.00% | Add +9050.0% | 183 | $455 |
| AdvisorNet Financial, Inc | 0.00% | New | 176 | $438 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 175 | $436 |
| Osaic Holdings, Inc. | 0.00% | Reduce -0.9% | 113 | $281 |
| Wells Fargo & Company | 0.00% | Add +3.0% | 34 | $85 |
| Barclays PLC | 0.00% | No change | 16 | $40 |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.0% | 11 | $27 |
| Allworth Financial LP | 0.00% | No change | 1 | $3 |
| Bank of America Corp. | 0.00% | Reduce -99.1% | 1 | $2 |
| Signaturefd, LLC | 0.00% | No change | 1 | $2 |
| Harbor Investment Advisory, LLC | 0.00% | No change | 1 | $2 |
| Global Retirement Partners, LLC | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | No change | 20 | $0 |
| Macquarie Group Ltd. | 0.00% | New | 88 | $0 |
| Benjamin F. Edwards & Company, Inc. | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is HEPA's weight in each manager's 13F, not the share of Hepion Pharmaceuticals Inc. the manager owns.